Synthetic cannabidiol secured for acne program
29 July, 2016Botanix Pharmaceuticals has secured a supply of synthetic cannabidiol, manufactured at commercial scale by its US-based partner, to be used in the development of a treatment for skin diseases.
Positive preliminary results from wet AMD trial
26 July, 2016Opthea has announced positive data from its ongoing first-in-human clinical trial of OPT-302, a VEGF-C/D 'Trap' therapy for wet age-related macular degeneration.
What do gravitational waves and bone grafting have in common?
19 July, 2016 by Lauren DavisWhat if you could grow a bone in the lab using the power of vibration? It sounds fantastic, but UK researchers have collaborated on a method which could do exactly that.
Sleep disorder start-up debuts on the ASX
19 July, 2016Sleep disorder device manufacturer Oventus Medical has made its debut on the Australian Securities Exchange, raising $12 million from a fully subscribed IPO underwritten by Bell Potter.
AusBiotech CEO Anna Lavelle stepping down
18 July, 2016The CEO of AusBiotech, Dr Anna Lavelle, will hand over leadership of the organisation after more than 11 years of service to the Australian biotechnology industry.
FDA clears PeriCoach to go over the counter
13 July, 2016Analytica has been granted FDA clearance for its PeriCoach medical device, previously available in the US by prescription only, to be sold over the counter.
Drug discovery via an online portal
13 July, 2016The Compounds Australia Structure PoRtal (CASPeR) is a newly released online portal providing access to the data of more than 50,000 different compounds and samples, linking Australian researchers in a way that has not been possible previously.
Orthocell approved for tennis elbow study
12 July, 2016Regenerative medicine company Orthocell has received ethics approval to conduct a study comparing surgery for severe tennis elbow to the company's minimally invasive cell therapy Ortho-ATI injection.
Biopharma innovation centre coming to UQ
05 July, 2016A $10 million biopharmaceutical centre will be established at The University of Queensland to train the next generation of scientists and enhance Australia's capabilities in the pharmaceutical sector.
New asthma treatment being trialled at UQ
29 June, 2016Researchers at UQ's School of Biomedical Sciences are testing a new drug that has the potential to reverse or slow the development of asthma, as opposed to current drugs which just ease the symptoms of the disease.
Better late than never — Golden Goose Award goes to 'sex life of the screwworm' researchers
29 June, 2016Edward F Knipling and Raymond C Bushland, who were ridiculed for their study of the sex life of the screwworm fly during the mid-20th century, will be posthumously honoured later this year with a Golden Goose Award.
Mass spectrometry for pharma and biotech
23 June, 2016OMass Technologies has used native mass spectrometry to conquer the challenge of deciphering the interactions of membrane proteins.
Johnson & Johnson encourages innovation in Queensland
23 June, 2016The Johnson & Johnson Innovation Partnering Office @ QUT aims to improve access to global health and medical innovation in Queensland and beyond.
Stem cell company prepares for Phase 1 clinical trial
22 June, 2016Cynata Therapeutics intends to file an application for regulatory approval with the MHRA for a Phase 1 clinical trial of CYP-001, the company's lead Cymerus mesenchymal stem cell (MSC) product.
Improved drug delivery inside cells
15 June, 2016Drug delivery company Phylogica has announced the improved delivery of antisense oligonucleotide drugs inside cells.
